DX Earnings Report: Lab Companies Continue to Grow but at a Slower Rate
From - Laboratory Industry Report
The diagnostics industry got off to a so-so start with PAMA reimbursement cuts, a weak flu season relative to…
From - Laboratory Industry Report
The diagnostics industry got off to a so-so start with PAMA reimbursement cuts, a weak flu season relative to…
From - Laboratory Industry Report
The diagnostics industry capped a robust 2018 with most companies posting strong fourth quarter results. Of course…
...
From - Laboratory Industry Report
One quarter into its existence, the new PAMA Medicare Part B fee schedule seems to be having only a marginal impact on at least publicly traded labs…
From - National Intelligence Report
One quarter into its existence, the new PAMA Medicare Part B fee schedule seems to be having only a marginal impact on at least publicly traded labs. In fact, the recently published…